A Cleveland Clinic study finds Ozempic-style GLP-1 drugs may significantly slow the spread of several obesity-related cancers ...

The eagerly awaited full dataset from arguably the most pivotal pancreatic cancer trial in decades is now public.Based on the ...

Eli Lilly said its targeted cancer therapy Retevmo significantly reduced the risk of disease recurrence or death in patients with e ...

Akeso (AKESF) said its experimental lung cancer treatment ivonescimab improved overall survival compared with a widely used ...

About half of people diagnosed with metastatic non-small-cell lung cancer don't receive systemic therapies, pointing to ...

GLP-1 receptor agonists may help mitigate progression of at least some obesity-related cancers, according to retrospective ...

The EMA has backed new and expanded uses for multiple cancer drugs, signaling a push toward biomarker-driven, earlier-line ...

Scientists at the world's largest cancer conference have hailed the start of a new drug 'revolution'.

Upfront treatment options set to expand for NSCLC patients with EGFR exon 20 inse ...

Onc.AI, a digital health company developing computational biomarkers and decision-support products in oncology using Deep Learning imaging AI, today announced positive external validation results for ...

Every home should be tested,” said Michael Walther, a longtime radon professional who has worked with the federal agency ...

A lung cancer drug developed by Akeso Inc. extended patients’ lives by about four months in a late-stage trial in China, results that will likely raise expectations for a closely watched new class of ...